Flo Health

Flo Health operates the world’s leading women’s health app focused on menstrual cycle tracking, ovulation/fertility prediction, pregnancy monitoring, perimenopause/menopause support, and general reproductive wellness. The company leverages advanced data analytics and generative AI to deliver highly personalized insights to over 75 million monthly active users worldwide. Its “Anonymous Mode” feature has received industry recognition for privacy innovation. As of mid–2024 the company reached unicorn status following a $200M Series C round led by General Atlantic. No clinical drug/device programs—product impact measured in user engagement/growth rather than traditional clinical endpoints.